The HL7® Survival Guide – 2 Year Anniversary
It’s been 2 years this fall that we started publishing the HL7® Survival Guide chapter by chapter. It’s proven to be our most popular download
Home » HL7 Survival Guide
It’s been 2 years this fall that we started publishing the HL7® Survival Guide chapter by chapter. It’s proven to be our most popular download
Our readers have been asking, and now it’s here: the complete HL7® Survival Guide, now available as a single PDF download. Download your copy now.
Resources For vendor performance rankings, see the KLAS Research website. For a current view of the HL7® interface market within healthcare, see the 2018 HL7®
Anonymization This is a type of de-identification where all sensitive data is removed. More details and a definition of anonymization are available in a previous
Now we’re coming full circle. Throughout Chapters 6 through 10, we talked about creating interfacing artifacts, assets, and documentation: profiles, gap analyses, test plans, test
In the last chapter, we explained what to aim for in test messages and message samples. Next you need to map out your processes and
In the previous chapter, we covered what you need to know when testing your interface. While the right test tool is helpful, you need to
In the last two chapters, we covered some of the requirements-related artifacts you need. Now it’s time for testing, which you conduct at different phases
This chapter helps you set up a crucial HL7® requirements document: the gap analysis. Once you have profiles for your source and destination systems, you
The first five chapters of this Survival Guide have helped you think strategically about your interfacing project. Now we’re going to dive into the nitty-gritty
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.